Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon

11 leading cardiology societies collaborate on new AUC for chronic coronary disease

The new AUC document, which examines the treatment of both symptomatic and asymptomatic patients, was published in full in the Journal of the American College of Cardiology.

A figure from the HRS remote monitoring consensus document on staffing challenges with remote monitoring.

Electrophysiology experts issue recommendations for remote monitoring of CIEDs

The Heart Rhythm Society released a new expert consensus statement on the management of remote device clinics for implantable EP devices.

Assert-IQ Abbott ICM

Abbott’s new long-term ICM gains FDA approval

The newly approved device is powered by Bluetooth technology and available with a three- or six-year battery.

WHO warns against use of artificial sweeteners, highlighting CVD and diabetes risks

The World Health Organization has published a new guideline recommending against the use of artificial sweeteners such as aspartame and sucralose to lose weight or reduce the risk of noncommunicable diseases.

FDA grants fast track designation to Bayer’s new drug for preventing stroke in AFib patients

The new drug, asundexian, is currently the subject of two multicenter Phase III studies—the OCEANIC-AF trial and OCEANIC-STROKE trial—focused on its safety and efficacy.

Researchers question FFR-CT’s value compared to other cardiac imaging options

FFR-CT has grown in popularity due its ability to provide noninvasive evaluations of patients being considered for revascularization procedures. According to a new study in JACC: Cardiovascular Imaging, however, stress imaging strategies may still provide more value in certain scenarios. 

FDA expands dapagliflozin approval to cover all heart failure patients

The FDA has previously approved the SGLT2 inhibitor in patients with HFrEF, but not HFmrEF or HFpEF

Exploring diversity, compensation among academic cardiothoracic surgeons

New research presented at the 103rd Annual Meeting of the American Association for Thoracic Surgery examined the lack of diversity seen in this important specialty. 

Displaying 289 - 296 of 440

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.